Fibromyalgia drug tested in elderly: does age matter?
NCT ID NCT07413367
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how the fibromyalgia medication TNX-102 SL (taken under the tongue) is processed in the body of older adults (65+) compared to younger adults (18-45). About 50 healthy participants will receive a single dose, and researchers will measure drug levels and safety. The goal is to understand if age affects how the drug works, which can help guide proper dosing for older patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PHASE 1 are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Syneos Health Clinique, Inc.
Québec, Quebec, G1P 0A2, Canada